LAB Standard BioTools Inc: Company Long-Term Indebtedness

Official company branding of Fluidigm (LAB)

Standard BioTools Inc. (LAB) specializes in diagnostic laboratory research. This chart of share prices on GURU.Markets reflects the impact of high demand for external shipments of boards and lasers, with the indicator standing at 0.02. New top management is currently optimizing expenses, prioritizing the most profitable instruments. Additionally, the business is implementing energy-saving technologies and reducing toxic emissions at its production facilities.

LAB (fluidigm.com) Company Long-Term Debt history from 04/28/2023 to 10/28/2026

Analytical breakdowns for Fluidigm (LAB)

- price and consensus price forecast:
Stock Price fluidigm.com|LAB - Price Target Chart
- market capitalization data:
Market Capitalization Standard BioTools|LAB - Enterprise Value
- book capitalization data:
Book Value per Share Standard BioTools|LAB - Company Book Value|Market Value to Book Value Ratio fluidigm.com|LAB - Cumulative Company Assets
- debt and liquidity data:
Debt to Capital Standard BioTools Inc.|LAB - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Standard BioTools Corp|LAB - Company Aggregate Debts|Debts to Net Assets Standard BioTools|LAB - Company Long-Term Debt|Short-Term Debt Volume Standard BioTools
General company analysis:fluidigm.com (LAB)
Manufactured products of Standard BioTools Inc.

Conservative capital demands absolute transparency regarding debt load to assess business resilience amid tight monetary policy. This indicator measures the cost of long-term debt obligations, allowing for a comparison between the cost of capital and operating liquidity. The modernization of assembly lines and the upgrading of calibration systems at Standard BioTools Inc. (LAB) confirm the targeted use of funds, as reflected in the company's long-term debt dynamics.

Competing companies

agilent.com - Company Long-Term Debts|Quest Diagnostics Incorporated (DGX) - Company Long-Term Debt|ILMN - Company Long-Term Indebtedness|EXAS: Company Long-Term Debts|RVTY (Revvity Corp) - Company Long-Term Debts|Company Long-Term Debt Bio-Rad Laboratories|Company Long-Term Debt anbio.com (NNNN)|Sotera Health - Company Long-Term Liabilities|Long-Term Debt QDEL (Quidel Corporation)|Company Long-Term Debt OPK|Long-Term Debt Volume CareDx CDNA|Company Long-Term Debts MRVI (Maravai LifeSciences)|FLGT: Long-Term Debt Volume|Cytek Biosciences - Company Long-Term Debt|OSUR (OraSure Technologies, Inc.) - Long-Term Debt Volume|XGN: Company Long-Term Debt|Long-Term Debt Volume MDxHealth, Inc. (MDXH)|Company Long-Term Liabilities Lucid Diagnostics Inc.|Amount of Long-Term Liabilities prenetics.com (PRE)|Company Long-Term Debts IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech PLC - Company Long-Term Debts|ProPhase (PRPH) - Company Long-Term Debt|AIMD - Company Long-Term Indebtedness|Company Long-Term Debts Co-Diagnostics, Inc.|heartsciences.com (HSCS) - Company Long-Term Indebtedness|BMRA (Biomerica) - Company Long-Term Debts|Company Long-Term Debts CDIO|Virax Biolabs Group Ltd (VRAX) - Company Long-Term Debt|Company Long-Term Loans and Borrowings Bluejay Diagnostics Corp (BJDX)|AWH - Company Long-Term Debts|AXDX - Company Long-Term Indebtedness|Company Long-Term Liabilities CENTOGENE (CNTG)|ENZ - Company Long-Term Loans and Borrowings|fresh2.co (FRES) - Company Long-Term Debts|Genetic Technologies Limited (GENE) - Company Long-Term Debt|ME: Company Long-Term Debts|Long-Term Debt Volume PMD